79 results on '"Burra, Patrizia"'
Search Results
2. Role of nonneoplastic PVT in the natural history of patients with cirrhosis and first diagnosis of HCC
3. Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injury
4. 424.4: The Protection From CMV Infection in Solid Organ Transplants Is Highly Dependent on CMV T-Cell Specific Immunity And Type of Organ Transplant
5. Women Leadership in Liver Transplantation—Results of an International Survey
6. Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model
7. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients
8. Letter to the editor: Is PAI‐1 a thrombotic biomarker in NASH cirrhosis?
9. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
10. The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin
11. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome
12. Ethical Issues in the COVID Era: Doing the Right Thing Depends on Location, Resources, and Disease Burden
13. Solid Organ Transplantation During COVID-19 Pandemic: An International Web-based Survey on Resources’ Allocation
14. Machine Perfusions in Liver Transplantation: The Evidence‐Based Position Paper of the Italian Society of Organ and Tissue Transplantation
15. mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
16. Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
17. Outcomes of Liver Transplant for Adults With Wilson’s Disease
18. P: 19 Predictive Value of Induced Hyperammonaemia and Neuropsychiatric Profiling in Relation to the Occurrence of Post-tips Hepatic Encephalopathy (HE)
19. Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation
20. Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation
21. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis
22. The ILTS Consensus Conference on NAFLD/NASH and Liver Transplantation: Setting the Stage
23. The ILTS Consensus Conference on NAFLD/NASH and liver transplantation
24. The Efficacy of CMV Specific Immune Reconstitution is Highly Dependent on Donor/Recipient Serostatus and Type of Solid Organ Transplanted
25. The Health Care Transition of Youth With Liver Disease Into the Adult Health System: Position Paper From ESPGHAN and EASL
26. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients
27. Long-term care of transplant recipients
28. Reply
29. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals
30. Transplantation for acute alcoholic hepatitis
31. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients
32. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates
33. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients
34. Beneficial role of terlipressin in decompensated cirrhotics with spontaneous bacterial peritonitis
35. Organ allocation for liver transplantation: One size does not fill all
36. Liver Transplantation for Alcoholic Liver Disease
37. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
38. HCC criteria for liver transplantation: Controversies
39. Age and equity in liver transplantation: An organ allocation model
40. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial
41. Risk Factors for Central Pontine and Extrapontine Myelinolysis After Liver Transplantation
42. Sorafenib use in the transplant setting
43. Central Pontine and Extrapontine Myelinolysis: Risk Factors and Clinical Expression in Liver Transplanted Patients (P6.028)
44. A Prospective Policy Development to Increase Split-Liver Transplantation for 2 Adult Recipients
45. Can liver transplantation provide the statistical cure?
46. Cavoportal Hemitransposition Associated to Portoportal Anastomosis for Liver Transplant in Portomesenteric Thrombosis
47. Trasplante hepático en la hepatopatía alcohólica
48. Long-term quality of life for transplant recipients
49. Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome
50. Liver transplantation for alcoholic liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.